Analysis of NT-proBNP and uric acid due to left ventricle hypertrophy in the patients of aortic valve disease

Evaluation NT-proBNP and uric acid as markers of left ventricle hypertrophy

  • Muhammad Ishtiaq Jan Quaid -I- Azam University, Islamabad
  • Riaz Anwar Khan
  • Aneesa Sultan
  • Anwar Ullah
  • Ayesha Ishtiaq
  • Iram Murtaza
Keywords: NT-proBNP, Uric acid, Aortic valve, Heart failure, Left ventricle hypertrophy

Abstract

Objective: To evaluate the concentration of N terminal proBNP (NT-proBNP) and partially the serum uric acid in the severe condition of aortic valve dysfunction for assessment of left ventricle hypertrophy.

Methods: The study was conducted in the signal transduction lab department of biochemistry Quaid-I-Azam University, Islamabad from September 2013 to February 2017. NT-proBNP and serum uric acid were measured in one hundred patients of aortic valve dysfunction. The patients were divided into three main groups: 1) Aortic stenosis, 2) Aortic regurgitation, and 3) Aortic stenosis with Aortic regurgitation. The results were compared between disease and controls groups.

Results: High level of plasma NT-proBNP was detected in all the three disease groups of aortic valve (stenosis, p<0.001), (regurgitation, p<0.001) and (stenosis with regurgitation, p<0.001). In addition, non-significantly increased level of serum uric acid was also observed in left ventricle hypertrophy in all the three respective disease groups of aortic valve.

Conclusion: Increased secretion of NT-proBNP during cardiac remodeling can be related to the severity of left ventricle hypertrophy due to aortic valve abnormality in all the disease groups of severe stenosis, severe regurgitation, and combine disease condition of severe stenosis and severe regurgitation. However, non-significant increase in uric acid concentration is also identified which may be due to one of the factors involved in left ventricle hypertrophy in all the three disease groups of aortic valve. The interaction of uric acid with NT-proBNP during cardiac remolding due to aortic valve dysfunction is still not clear.

How to cite this:
Jan MI, Khan RA, Sultan A, Ullah A, Ishtiaq A, Murtaza I. Analysis of NT-proBNP and uric acid due to left ventricle hypertrophy in the patients of aortic valve disease. Pak J Med Sci. 2019;35(1):183-188. doi: https://doi.org/10.12669/pjms.35.1.148

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published
2019-01-23
How to Cite
Jan, M. I., Khan, R. A., Sultan, A., Ullah, A., Ishtiaq, A., & Murtaza, I. (2019). Analysis of NT-proBNP and uric acid due to left ventricle hypertrophy in the patients of aortic valve disease: Evaluation NT-proBNP and uric acid as markers of left ventricle hypertrophy. Pakistan Journal of Medical Sciences, 35(1). https://doi.org/10.12669/pjms.35.1.148